ECT2 and breast carcinoma: Disease analysis from Oncomine displays that the mRNA expression level of ECT2 is upregulated in breast carcinoma from 12 out of 43 analyses in 4 of 10 datasets 53, and ECT2 is highly expressed in distinct histological breast cancer samples (Figure S1A).